These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1600129)

  • 21. Complement activation induces the expression of decay-accelerating factor on human mesangial cells.
    Shibata T; Cosio FG; Birmingham DJ
    J Immunol; 1991 Dec; 147(11):3901-8. PubMed ID: 1719094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    Carney DF; Hammer CH; Shin ML
    J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of a complement regulatory protein in rat mesangial glomerulonephritis.
    Nishikage H; Baranyi L; Okada H; Okada N; Isobe K; Nomura A; Yoshida F; Matsuo S
    J Am Soc Nephrol; 1995 Aug; 6(2):234-41. PubMed ID: 7579090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The humoral and cellular factors of glomerular damage].
    Camussi G; Montrucchio G
    Ann Ital Med Int; 1992; 7(4):226-33. PubMed ID: 1298333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane signaling by complement C5b-9, the membrane attack complex.
    Nicholson-Weller A; Halperin JA
    Immunol Res; 1993; 12(3):244-57. PubMed ID: 8288945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation.
    Qiu W; Zhang Y; Liu X; Zhou J; Li Y; Zhou Y; Shan K; Xia M; Che N; Feng X; Zhao D; Wang Y
    J Pathol; 2012 Mar; 226(4):619-32. PubMed ID: 21984198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the complement regulator factor C8 binding protein on human glomerular cells protects them from complement-mediated killing.
    Schieren G; Schönermark M; Braunger M; Hänsch GM
    Exp Nephrol; 1994; 2(5):299-305. PubMed ID: 7812736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH; Carney DF; Hammer CH; Shin ML
    J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes.
    Pippin JW; Durvasula R; Petermann A; Hiromura K; Couser WG; Shankland SJ
    J Clin Invest; 2003 Mar; 111(6):877-85. PubMed ID: 12639994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.
    Bresnahan BA; Wu S; Fenoy FJ; Roman RJ; Lianos EA
    J Clin Invest; 1992 Dec; 90(6):2304-12. PubMed ID: 1361493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
    Fu X; Ju J; Lin Z; Xiao W; Li X; Zhuang B; Zhang T; Ma X; Li X; Ma C; Su W; Wang Y; Qin X; Liang S
    Sci Rep; 2016 Jul; 6():30239. PubMed ID: 27444648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis.
    Brandt J; Pippin J; Schulze M; Hänsch GM; Alpers CE; Johnson RJ; Gordon K; Couser WG
    Kidney Int; 1996 Feb; 49(2):335-43. PubMed ID: 8821815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of complement C5b-9 binding to cells by flow cytometry.
    Moskovich O; Fishelson Z
    Methods Mol Biol; 2014; 1100():103-8. PubMed ID: 24218253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system.
    Radeke HH; Resch K
    Clin Investig; 1992 Sep; 70(9):825-42. PubMed ID: 1450638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms.
    Zhang Z; Zhang X; Fang X; Niimi M; Huang Y; Piao H; Gao S; Fan J; Yao J
    Redox Biol; 2017 Aug; 12():571-581. PubMed ID: 28390315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complement attack phase: control of lysis and non-lethal effects of C5b-9.
    Hänsch GM
    Immunopharmacology; 1992; 24(2):107-17. PubMed ID: 1473962
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-vitronectin antibodies enhance anti-Thy-1-induced proteinuria in PVG/c, but not in Wistar rats.
    Van Dixhoorn MG; Salazar-Exaire D; Sato T; Daha MR; Quigg RJ; Bruijn JA; Couser WG; De Heer E
    J Am Soc Nephrol; 1998 Jun; 9(6):994-1007. PubMed ID: 9621282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
    Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.